Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Overview of attention for article published in The Lancet, June 2011

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 11 X users
patent: 17 patents

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 198 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 12 X posts from 11 X users, with an upper bound of 33,240 followers.

RT @CDiabetesSLP: Terapia basada en antígeno con vacuna de ácido glutámico descarboxilasa (GAD) en pacientes con diabetes tipo 1 de inicio…

Terapia basada en antígeno con vacuna de ácido glutámico descarboxilasa (GAD) en pacientes con diabetes tipo 1 de inicio reciente: un ensayo aleatorizado doble ciego. https://t.co/9Fdwxp70xy https://t.co/Z3CTzNDznt

9. GAD-alum trial failed in type 1 diabetes http://t.co/Bud3Nl3D #diabetes

Terapia baseada em antígeno com vacina GAD em pacientes com início recente de DM 1 (Lancet) http://t.co/7IRyp2Ni

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.